Head of Early Cell Therapy Assets & Strategy

A leading biopharmaceutical company is seeking a Head of Early Assets in Cell Therapy. This role involves shaping early pipeline strategy from preclinical through clinical development and requires a matrix leader who can integrate insights across R&D, Medical, and Market Access to define product positioning and go-to-market strategies. Candidates should have a strong background in biopharma with commercial experience in cell therapy and a Bachelor’s degree in a relevant field. This is a full-time position based in Gaithersburg, MD. #J-18808-Ljbffr